The marked increase in the total serum MATERIALS AND METHODS Patients. The sera of patients with acute hepatitis A were collected at the time of admission to the hospital (To) and at 6 weeks (T1), 3, 6 , and 12 months later. In each case, a hepatitis B was serologically excluded (negative for hepatitis B surface antigen and IgM antihepatitis B core). An acute hepatitis A infection was diagnosed by the detection of IgM anti-HAV, which decreased during convalescence. The acute stage of the disease was verified in each case by elevated levels of serum alanine lactate aminotransferase and serum bilirubin and by liver biopsy.
Elevated levels of immunoglobulin are common in many different liver diseases (4, 9, 11) . Probably the most drastic effect is the marked increase in the total serum immunoglobulin M (IgM) during the acute phase of hepatitis A, the nature of which is essentially obscure. We tested three different hypotheses to explain the elevated level of IgM: (i) the production or metabolism of IgM could be altered in toto; (ii) the increase in IgM could be caused by the high titers of IgM antibodies against hepatitis A virus (IgM anti-HAV); (iii) other antigens, not related to HAV, could induce high titers of IgM antibodies during the acute disease. The results of this study rule out the first two hypotheses and support the third one: very high titers of IgM antibodies against certain gut bacteria suggest that bacterial antigens could make up the marked increase in the serum IgM during acute hepatitis A.
MATERIALS AND METHODS Patients. The sera of patients with acute hepatitis A were collected at the time of admission to the hospital (To) and at 6 weeks (T1), 3, 6 , and 12 months later. In each case, a hepatitis B was serologically excluded (negative for hepatitis B surface antigen and IgM antihepatitis B core). An acute hepatitis A infection was diagnosed by the detection of IgM anti-HAV, which decreased during convalescence. The acute stage of the disease was verified in each case by elevated levels of serum alanine lactate aminotransferase and serum bilirubin and by liver biopsy.
Determination of IgM anti-HAV. Microtiter plates
(Nunc flat-bottom polystyrene plates) were incubated with 5 R±g of rabbit IgG fractions per ml against human IgM (,u-chain specific, absorbed with negative anti-HAV IgG; our own reagents) in 0.02 M sodium phosphate buffer (pH 7.2) for 48 h at 4°C, washed, and dried. Test sera were incubated 1:100 in 0.02 M sodium phosphate (pH 7.2)-0.13 M NaCl containing 0.1% heat-aggregated, negative anti-HAV human IgG to block the nonspecific binding of rheumatoid factor (3). After 2 h at 37°C, serum dilutions were removed by aspiration, and the wells were washed three times with washing liquid (0.5% Tween 20 in 0.2 M phosphate [pH 7.2]-0.13 M NaCl). HAV antigen was extracted from stools by shaking with 5 volumes of phosphate-buffered saline (PBS) and glass beads and clarifying for 30 min at 10,000 rpm in an SW40 rotor.
A suitable dilution of the extract was incubated for 10 h at 37°C in the microtiter wells, and subsequently 50 ,ul of anti-HAV horseradish peroxidase conjugate was added for 2 h at 37°C. The IgG for conjugation was isolated from a hepatitis A convalescent serum by ionexchange chromatography. The conjugate was diluted in a pool of 30 to 50 negative anti-HAV human sera to 2 to 5 ng of conjugate per ml. After three washings, ortho-phenylenediamine and H202 (3) were added, and after 30 min the reaction was stopped by 2 M H2SO4. The reaction product was measured at 493 nm in a photometer.
Previous studies had shown that in this assay the color was proportional to the ratio between anti-viral IgM and the total IgM up to serum dilutions of 1:5,000 (3) . For standardization of the assay, a highly positive reference serum was diluted 1:100 in buffer (corresponding to 1,000 arbitrary units of IgM anti-HAV) and thereafter to 1:400, 1:1,600, 1:6,400, 1:25,600, and (200 ,ul) were mixed with 100 ,ul of bacterial suspension (for S. faecalis, 300 ,ul) in 1.5-ml V-vials. After 60 min at 37°C, the bacteria-antibody complexes were centrifuged and washed three times with 1 ml of PBS-EDTA by centrifugation. The complexes were incubated with anti-human IgM (,u-chains) globulin from rabbits which was labeled with horseradish peroxidase (DAKO) for 60 min at 37°C. The Figure 2 shows the lack of correlation between the ratios of the two variables for 24 patients. The correlation coefficient was 0.07.
Seventeen cases showed the most typical behavior: both parameters decreased between To and Tj; thus, both To/Tl ratios were larger than 1 (Fig. 2, right upper field) . However, even for these cases, a quantitative correlation is clearly absent. In five patients, the total IgM decreased as usual, but IgM anti-HAV increased (Fig. 2, right lower field). Two patients showed the uncommon pattern that the total IgM increased during early convalescence (Fig. 2, left upper  field) . Again, the titer of IgM anti-HAV was independent of the total IgM and decreased in both cases.
Kinetics of antibacterial IgM. were read at the parallel parts of the titration curves. In the case shown in Fig. 3 , the To/Tl ratio of the total serum IgM was 3.4, and that of IgM antibodies against B.fragilis was 14; against S. faecalis the ratio was 2.1, whereas the titers against E. coli remained constant. Table 2 shows the titer ratios for the IgM antibodies against these three bacteria in 18 patients.
In 17 of 18 patients, the titers against B.
fragilis decreased from To to T1 by factors ranging between 22.6 and 2. The one patient with the constant titer also had a constant level of total IgM. The titers against S. faecalis decreased in 12 of 13 patients by factors ranging between 11.3 and 1.5. The behavior of the IgM antibodies against E. coli was inconsistent: in 5 of 11 patients, they decreased; 4 patients had constant titers, and in 2 patients the antibodies increased.
The titer ratios (To/1) of the antibodies against B. fragilis were qualitatively correlated with the ratio of the total IgM. Whenever the total IgM decreased significantly, the antibacterial IgM also decreased. In general, the specific IgM against B.fragilis decreased considerably more than did the total IgM during convalescence; therefore, only a weak (but significant) correlation was obtained (r = 0.74; P < 0.001). It is highly improbable that the observed titer decreases were accidental variations. In serial samples taken more than 9 weeks after To, the IgM titers against B. fragilis and S. faecalis and the total serum IgM were constant within a factor of 2. As an example, the time course of the total IgM and antistreptococcal IgM is shown for one patient during a period of 2 years (Fig. 4) .
Specificity of increased antibacterial IgM. The increase in antibacterial IgM in hepatitis A patients is probably restricted to the antigens of gut bacteria. IgM antibodies against S. epidermidis were not detectable in any of the 15 patients examined.
The preabsorption of the sera with a highly concentrated bacterial suspension reduced the homologous IgM titers by factors of 10 to 100. When the concentrations of the total serum IgM were measured before and after absorption with suspensions of B. fragilis, S. faecalis, or E. coli, slight reductions of up to 10% were observed. However, these decreases in the total IgM were not significantly larger than the error of the method.
The IgM specificity of the enzyme immunoassay used in this study was confirmed in several samples by the sedimentation behavior of the antibacterial antibodies as 19S molecules.
Rheumatoid factor could potentially cause false-positive results. However, none of the sera was positive in a latex test at a dilution of 1:20 or in an enzyme-linked immunosorbent assay (ELISA) which was 10 times more sensitive than the latex test.
Antibacterial IgM in hepatitis B. Moderate increases in the total IgM occur during the acute phase of hepatitis B (8) . In eight patients the titers of IgM against B. fragilis were assayed (Table 3 ). In five of six patients with clearly elevated IgM concentrations, the antibacterial titer was significantly higher at To than at T1.
Two patients showed constant titers of both the total serum IgM and antibacterial IgM. In two other patients (marked in Table 3 with a asterisk), sera from the time before onset were available. In these pre-sera, the total IgM concentrations and anti-Bacteroides sp. IgM titers were the same as in the sera taken during convalescence (Fig. 5) .
DISCUSSION
The drastic increase in the total serum IgM in acute hepatitis A begins 3 to 4 days after the first rise in transaminases and reaches peak values at the onset of clinical symptoms. Thereafter, the IgM concentration returns to its initial values within several weeks (4).
It has been suggested that the production of immunoglobulins is nonspecifically increased during liver diseases (5 increased at the onset of the disease and would return uniformly to lower levels or zero during convalescence. The constancy of the isohemagglutinin during and after the disease is not on September 6, 2017 by guest http://iai.asm.org/ Downloaded from against B. fragilis, S. faecalis and, to a lesser degree, against E. coli suggests that the excess of IgM is probably induced by certain antigens not directly related to HAV. The weak, but highly significant, correlation between IgM titers against B. fragilis and the total IgM concentration points to an important role for bacterial antigens. Absorption experiments failed to prove the antibacterial nature of the excess IgM, although a small effect was found. In addition, we used only one strain ofB. fragilis, S.faecalis, or E. coli as the antigen. If there are great antigenic differences between the bacterial strains from different patients, only the small fraction of cross-reacting antibodies would be detectable in this study. For future work, autologous strains of the patients could be used as the antigens to investigate the nature of the increased IgM in more detail.
Elevated titers of serum agglutinins to E. coli and B. fragilis during acute hepatitis have also been reported by Triger and Wright (10) . In serial sera, they found, in contrast to this study, that the titers peaked against E. coli 2 months after the onset of the disease. However, neither the etiology of the hepatitis nor the antibody class was clearly defined in that study.
B. fragilis is, together with other Bacteroides species, the most abundant bacterium in the gut. The finding that the titer of anti-B. fragilis IgM correlated best with the total IgM is consistent with the conclusion that bacterial antigens may induce a very strong IgM response during acute hepatitis A. Recently, it has been reported (6) that Kupffer cells are almost exclusively responsible for the clearance of bacterial products, such as endotoxin. It has earlier been suggested (1) that the liver has an important role as a barrier against the entrance of bacterial antigens into the bloodstream via the portal vein. Possibly, the filter effect of the reticuloendothelial system in the liver is severely impaired at the onset of acute hepatitis A. A similar effect, although less pronounced seem to occur in hepatitis B also. Further studies will be necessary to elucidate the potential role of gut bacteria in acute hepatitis.
